In transgenic mice, p38 inhibition was reported to correlate with COX-2 expression and inhibit UVB irradiation-induced skin cancer proliferation and apoptosis, indicating that p38 can be a major target for pharmacological or non-pharmacological interventions [42]. The gene discussed is MAPK14; the disease is skin cancer.